๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Transcription factor AP-1 in esophageal squamous cell carcinoma: Alterations in activity and expression during Human Papillomavirus infection

โœ Scribed by Showket Hussain; Alok C Bharti; Irfana Salam; Mohammad Akbar Bhat; Mohammad Muzaffar Mir; Suresh Hedau; Mushtaq A Siddiqi; Seemi Farhat Basir; Bhudev C Das


Book ID
115011693
Publisher
BioMed Central
Year
2009
Tongue
English
Weight
863 KB
Volume
9
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Human papillomavirus infection in esopha
โœ R. Benamouzig; F. Pigot; G. Quiroga; P. Validire; S. Chaussade; F. Catalan; D. C ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 446 KB ๐Ÿ‘ 1 views

Recent studies have suggested that esophageal HPV infection could be a risk factor for esophageal squatnous-cell carcinoma. The aims of our study were to assess the presence of HPV esophageal infection among French patients with esophageal squamous-cell carcinoma and to compare the prevalence of thi

Alcohol, smoking and papillomavirus infe
โœ Giorgio Talamini; Paola Capelli; Giuseppe Zamboni; Marina Mastromauro; Marzia Pa ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 78 KB ๐Ÿ‘ 2 views

Esophageal papilloma, an infrequent benign tumor, and esophageal squamous-cell carcinoma sometimes appear to be associated with human papillomavirus (HPV) infection, HPV being implicated in anogenital carcinogenesis. Our aim was to assess whether there is any epidemiological difference in terms of r

Expression of autocrine motility factor
โœ Kentaro Maruyama; Hideomi Watanabe; Hitoshi Shiozaki; Takuya Takayama; Junji Gof ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 796 KB

Autocrine motility factor and its receptor (gp78) have been shown to play an important role in tumor cell migration, invasion and metastasis. We have detected gp78 expression in buffered-formalin-fixed, paraffin-embedded sections of esophageal squamous cell carcinomas using an anti-gp78 monoclonal a